Home / Recalls / Lowlite Investments, Inc. D/B/A Olympia Pharmacy / D-779-2013

D-779-2013 Class II Ongoing

Recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy — Orlando, FL

Recall Details

Product Type
Drugs
Report Date
July 17, 2013
Initiation Date
May 29, 2013
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product Description

Sermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL

Reason for Recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Distribution Pattern

Nationwide and PR

Code Information

A5811 Exp 11/30/13

Other recalls by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

  • D-747-2013 Class II — L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-784-2013 Class II — Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-710-2013 Class II — Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-706-2013 Class II — Bi mix, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-753-2013 Class II — Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-796-2013 Class II — Yohimbine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-702-2013 Class II — Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-720-2013 Class II — Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-698-2013 Class II — Aminocaproic Acid 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, (May 29, 2013)
  • D-794-2013 Class II — Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)